Literature DB >> 16772326

Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis.

Laura E Parton1, Patrick J McMillen, Yingnian Shen, Elizabeth Docherty, Erin Sharpe, Frédérique Diraison, Celia P Briscoe, Guy A Rutter.   

Abstract

Accumulation of intracellular lipid may contribute to defective insulin secretion in type 2 diabetes. Although Zucker diabetic fatty (ZDF; fa/fa) rat islets are fat-laden and overexpress the lipogenic master gene, sterol regulatory element binding protein 1c (SREBP-1c), the contribution of SREBP-1c to the secretory defects observed in this model remains unclear. Here we compare the gene expression profile of lean control (fa/+) and ZDF rat islets in the absence or presence of dominant-negative SREBP-1c (SREBP-1c DN). ZDF islets displayed elevated basal insulin secretion at 3 mmol/l glucose but a severely depressed response to 17 mmol/l glucose. While SREBP-1c DN reduced basal insulin secretion from ZDF islets, glucose-stimulated insulin secretion was not improved. Of 57 genes differentially regulated in ZDF islets and implicated in glucose metabolism, vesicle trafficking, ion fluxes, and/or exocytosis, 21 were upregulated and 5 were suppressed by SREBP-1c DN. Genes underrepresented in ZDF islets were either unaffected (Glut-2, Kir6.2, Rab3), stimulated (voltage-dependent Ca(2+) channel subunit alpha1D, CPT2, SUR2, rab9, syt13), or inhibited (syntaxin 7, secretogranin-2) by SREBP-1c inhibition. Correspondingly, SREBP-1c DN largely corrected decreases in the expression of the transcription factors Pdx-1 and MafA but did not affect the abnormalities in Pax6, Arx, hepatic nuclear factor-1alpha (HNF1alpha), HNF3beta/Forkhead box-a2 (Foxa2), inducible cyclic AMP early repressor (ICER), or transcription factor 7-like 2 (TCF7L2) expression observed in ZDF islets. We conclude that upregulation of SREBP-1c and mild increases in triglyceride content do not explain defective glucose-stimulated insulin secretion from ZDF rats. However, overexpression of SREBP-1c may contribute to enhanced basal insulin secretion in this model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772326     DOI: 10.1152/ajpendo.00067.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  18 in total

1.  A high mobility group box-containing transcription factor leads to diabetes risk.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2006-11-08       Impact factor: 4.599

2.  Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.

Authors:  Valeriya Lyssenko; Roberto Lupi; Piero Marchetti; Silvia Del Guerra; Marju Orho-Melander; Peter Almgren; Marketa Sjögren; Charlotte Ling; Karl-Fredrik Eriksson; Asa-Linda Lethagen; Rita Mancarella; Göran Berglund; Tiinamaija Tuomi; Peter Nilsson; Stefano Del Prato; Leif Groop
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1).

Authors:  Timothy J Pullen; Gabriela da Silva Xavier; Gavin Kelsey; Guy A Rutter
Journal:  Mol Cell Biol       Date:  2011-06-06       Impact factor: 4.272

Review 4.  Deactivating Fatty Acids: Acyl-CoA Thioesterase-Mediated Control of Lipid Metabolism.

Authors:  Veronika Tillander; Stefan E H Alexson; David E Cohen
Journal:  Trends Endocrinol Metab       Date:  2017-04-03       Impact factor: 12.015

Review 5.  Exocytosis mechanisms underlying insulin release and glucose uptake: conserved roles for Munc18c and syntaxin 4.

Authors:  Jenna L Jewell; Eunjin Oh; Debbie C Thurmond
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-01-06       Impact factor: 3.619

6.  TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women.

Authors:  Marilyn C Cornelis; Lu Qi; Peter Kraft; Frank B Hu
Journal:  Am J Clin Nutr       Date:  2009-02-11       Impact factor: 7.045

7.  Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.

Authors:  Luan Shu; Aleksey V Matveyenko; Julie Kerr-Conte; Jae-Hyoung Cho; Christopher H S McIntosh; Kathrin Maedler
Journal:  Hum Mol Genet       Date:  2009-04-21       Impact factor: 6.150

8.  SREBP1 is required for the induction by glucose of pancreatic beta-cell genes involved in glucose sensing.

Authors:  Frederique Diraison; Magalie A Ravier; Sarah K Richards; Richard M Smith; Hitoshi Shimano; Guy A Rutter
Journal:  J Lipid Res       Date:  2008-01-04       Impact factor: 5.922

9.  Disallowance of Acot7 in β-Cells Is Required for Normal Glucose Tolerance and Insulin Secretion.

Authors:  Aida Martinez-Sanchez; Timothy J Pullen; Pauline Chabosseau; Qifeng Zhang; Elizabeth Haythorne; Matthew C Cane; Marie-Sophie Nguyen-Tu; Sophie R Sayers; Guy A Rutter
Journal:  Diabetes       Date:  2016-02-09       Impact factor: 9.461

10.  Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase.

Authors:  Karine H Hellemans; Jean-Claude Hannaert; Bart Denys; Knut R Steffensen; Cindy Raemdonck; Geert A Martens; Paul P Van Veldhoven; Jan-Ake Gustafsson; Daniel Pipeleers
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.